Qilian International Holding Group (QLI): Price Target Chart

Symbol and logo of brand Qilian International Holding Group (QLI)

Qilian International (QLI) is implementing robotics to automate packaging and extraction within its Chinese facilities, minimizing manual labor. The business relies on the production of chemicals and traditional remedies, where margins are constrained by government procurement, and the indicator stands at 0.00. The holding company is expanding capacity and entering the organic fertilizer and veterinary markets to achieve diversification. The consensus dynamics are reflected in this chart of the asset's value.

Qilian International Corp (QLI): Price Target Chart from 07/04/2022 to 08/17/2024

Analytical breakdowns for Qilian International Holding Group Limited (QLI)

- market value and analyst target forecast:
Fundamental company analysis:qlsyy.net, QLI
Finished products of Qilian International Holding Group Limited

Assessing asset reliability requires comparing the market price with the aggregated fair value calculated via the average target prices of independent experts. The trend of the weighted average target from investment houses reflects the sensitivity of the Qilian International (QLI) valuation to Chinese regulatory risks within the antibiotics sector, where any downward revision signals a critical reassessment of the business's fundamental prospects.

Competitors of Qilian International

haleon.com (HLN) - Analyst Target Range|Price Target Chart Kenvue KVUE|Verona Pharma PLC - Price Target Chart|Jyong Biotech Corp - Analyst Consensus Forecast|Analyst Median Target Ligand Corp LGND|Amneal Pharmaceuticals (AMRX) - Price Target Chart|Forecast Levels Chart PRGO (perrigo.com)|ALVO (Alvotech SA) - Analyst Consensus Forecast|LQDA: Fair Value Consensus|Analyst Consensus Forecast GLPG|Analyst Consensus Forecast ANI Pharmaceuticals Corp (ANIP)|Price Target Chart MannKind Corporation MNKD|Fair Value Consensus AMPH|PCRX - Price Target Chart|ARS Pharmaceuticals Inc (SPRY) - Consensus Target|TBPH: Analyst Consensus Forecast|Aquestive Corp (AQST) - Analyst Consensus Forecast|Consensus Target SCPH|TECX: Fair Value Consensus|Price Target Chart Tonix Pharmaceuticals Holding Corp. (TNXP)|SXTC - Average Forecast Price|Eupraxia Pharmaceuticals Inc. - Consensus Target|Analyst Forecast Prices BHST (BioHarvest Sciences Inc)|eXoZymes Inc - Analyst Consensus Forecast|Fair Value Consensus ORMP (Oramed Pharmaceuticals)|ENTX: Analyst Consensus Forecast|Average Forecast Price MindWalk Holdings, Inc. (HYFT)|Price Target Chart ABVC BioPharma Inc|CPIX: Fair Value Consensus|Price Target Chart Quantum BioPharma Ltd (QNTM)|fibrogen.com (FGEN) - Analyst Target Range|Analyst Consensus Forecast TELO (Telomir Pharmaceuticals, Inc.)|Analyst Median Target Rani Therapeutics Holdings (RANI)|SNYR - Price Target Chart|RLYB: Price Target Chart|LEXX: Analyst Consensus Forecast|PULM - Analyst Median Target|PTHL (Pheton Holdings Limited) - Analyst Consensus Forecast|Analyst Consensus Forecast Aptorum|Price Target Chart Lyra Therapeutics, Inc (LYRA)|impactbiomedinc.com - Broker Consensus Forecast|TNF Pharmaceuticals, Inc. - Consensus Target|Fair Value Consensus YCBD|PainReform - Analyst Consensus Forecast|Analyst Median Target Altamira Therapeutics CYTO|Lipella (LIPO) - Price Target Chart|Broker Consensus Forecast OPTN|Consensus Target PIRS|PROC (procapsgroup.com) - Analyst Forecast Prices|Analyst Consensus Forecast PTPI|SLRN - Average Forecast Price|Price Target Chart TFF Pharma TFFP